YORQINTA
Live / Applied — Fifth extension granted (statement of use) (as of 23 Jan 2026)
What this means for you
Not registered yet, but its 29 Mar 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97335626
- Mark type
- Stylized text
- Filed
- 29 Mar 2022
- Published for opposition
- 07 Feb 2023
- Attorney of record
- Heather A. McDonald
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; Pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; Pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; Vaccines for human use
Owner
- Pfizer Inc., New York, NY, US
- Pfizer Inc., New York, NY, US
Prosecution history
- 24 Jan 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 23 Jan 2026 — SOU EXTENSION 5 GRANTED
- 02 Sept 2025 — SOU EXTENSION 5 FILED
- 23 Jan 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 03 Sept 2025 — SOU TEAS EXTENSION RECEIVED
- 02 Sept 2025 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 02 Sept 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 02 Sept 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 02 Sept 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 11 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 10 Mar 2025 — SOU EXTENSION 4 GRANTED
- 10 Mar 2025 — SOU EXTENSION 4 FILED
- 10 Mar 2025 — SOU TEAS EXTENSION RECEIVED
- 04 Sept 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 04 Sept 2024 — SOU EXTENSION 3 GRANTED